<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Anna-Elena Freyhardt on Medium]]></title>
        <description><![CDATA[Stories by Anna-Elena Freyhardt on Medium]]></description>
        <link>https://medium.com/@annaelenafreyhardt?source=rss-e979107d65f4------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*tKmnHb75cAkHxUiv9ANQqA.png</url>
            <title>Stories by Anna-Elena Freyhardt on Medium</title>
            <link>https://medium.com/@annaelenafreyhardt?source=rss-e979107d65f4------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Sat, 21 Nov 2026 07:06:13 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@annaelenafreyhardt/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Beyond Pink —  The Femtech Revolution in Germany]]></title>
            <link>https://medium.com/included-vc/beyond-pink-the-femtech-revolution-in-germany-a9126e344d48?source=rss-e979107d65f4------2</link>
            <guid isPermaLink="false">https://medium.com/p/a9126e344d48</guid>
            <category><![CDATA[venture-capital]]></category>
            <category><![CDATA[germany]]></category>
            <category><![CDATA[femtech]]></category>
            <category><![CDATA[inclusion]]></category>
            <dc:creator><![CDATA[Anna-Elena Freyhardt]]></dc:creator>
            <pubDate>Sat, 14 Dec 2024 21:03:13 GMT</pubDate>
            <atom:updated>2024-12-14T21:27:35.907Z</atom:updated>
            <content:encoded><![CDATA[<h3>Beyond Pink — The Femtech Revolution in Germany</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*t0g8SGzLxgYV0r7b0rFBAA.png" /></figure><p><em>Hi folks, I&#39;m Anna -Elena — Included VC Fellow (Class of&#39; 24). I&#39;m always up for a chat, so feel free to reach out on </em><a href="https://www.linkedin.com/in/anna-elena-freyhardt-ba2a671b4/"><em>LinkedIn</em></a><em>! Let&#39;s dive into today&#39;s topic: </em><strong><em>Femtech in Germany</em></strong><em> — a sector innovating women&#39;s health and wellness with transformative potential and inclusivity.</em></p><p>👉 <strong>The TL;DR</strong></p><p>📊 <strong>Germany&#39;s Femtech market</strong> offers promising investment opportunities, from early-stage startups innovating in fertility, hormonal health, and personalized wellness to companies tackling inclusivity, data privacy, and digital health platforms. With growing interest, this sector is poised for regional and national growth.</p><p>😬 <strong>Challenges remain</strong> as Femtech in Germany navigates regulatory hurdles, data privacy standards, and inclusivity gaps. Other issues include funding constraints in women&#39;s health tech and the need for solutions beyond reproductive health to address a broader spectrum of wellness needs.</p><p>🔥 <strong>Emerging segments</strong> in menstrual health, mental well-being, and support for non-binary and trans individuals are drawing attention, offering new possibilities for VCs ready to shape the future of health. As Michelle Obama wisely said,</p><blockquote>“Communities and countries and ultimately the world are only as strong as the health of their women.”</blockquote><figure><img alt="" src="https://cdn-images-1.medium.com/max/480/0*vPLz0q3Ut5bhXl0q.gif" /></figure><h3>✨ Germany&#39;s Femtech Boom: Addressing Both Potential and Pitfalls ✨</h3><p>During my university days, I took a course where a group pitched a product aimed at relieving menstrual cramps — a discreet, wearable heating pad. While I thought it was a brilliant idea, the all-male panel of professors dismissed it, suggesting it wasn&#39;t a big enough market. Instead, they recommended targeting outdoor activities like hiking.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/311/0*Nby-JyIRoiw7m_Kk.gif" /></figure><p>This anecdote, however personal, speaks to a much larger issue. As promising as it is, Femtech still faces critique and challenges, many of which stem from historical, systemic biases in healthcare and technology. For decades, healthcare has underserved women. The <a href="https://www.weforum.org/stories/2024/10/women-health-gap-healthcare-gender/">World Economic Forum states the harsh truth</a>: The women&#39;s health gap results in a loss of 75 million years of life each year due to poor health and early death. Closing this gap could give the 3.9 billion women worldwide an extra seven healthy days annually, totaling 500 extra days over their lifetimes.</p><p>We&#39;ve seen it time and again: women suffering in silence, as the <a href="https://heart.bmj.com/content/110/22/e4">study by Professors Kunadian</a> revealed in 2024, Women are 10% less likely than men to have their pain assessed when arriving at the hospital and wait about half an hour longer to see a doctor because they are seen as hysterical and men are seen as stoic. Furthermore, they are also less likely to receive pain medication. Additionally, a 2019 study of nearly 7 million people in Denmark by <a href="https://pubmed.ncbi.nlm.nih.gov/30737381/">Professor Brunak</a> revealed that women were diagnosed with various health conditions an average of four years later than men. It all comes back to the point that we have a historical data gap of the female body, and women are dying because, for millennia, medicine has functioned on the assumption that male bodies can represent humanity as a whole, told <a href="https://www.standard.co.uk/futurelondon/health/gender-data-gap-caroline-criado-perez-on-how-healthcare-is-systematically-discriminating-against-women-a4246221.html">Criado Perez</a>.</p><p>And let&#39;s not forget the reality: <a href="https://www.weforum.org/stories/2023/01/davos2023-womens-health-rethinking-the-cost-as-an-investment-for-societal-gain/">globally, only 4% of research and development</a> funding is dedicated to women&#39;s health — despite women comprising 50% of the population.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*vI0IkVXmymoC5COnCMMoow.png" /><figcaption>Take a closer look — still 50%? Congrats on seeing the potential 🎊</figcaption></figure><p>This oversight leads to the underdiagnosis of a variety of conditions often dismissed as &quot;women&#39;s issues,&quot; such as <a href="https://www.mayoclinic.org/diseases-conditions/endometriosis/symptoms-causes/syc-20354656">endometriosis</a>, which affects approximately <a href="https://www.yalemedicine.org/conditions/endometriosis#:~:text=Endometriosis%20is%20a%20common%20condition,with%20pelvic%20pain%20have%20endometriosis.">10% of women</a>. Endometriosis typically takes 6 <a href="https://www.newscientist.com/article/2413278-endometriosis-takes-6-years-to-be-diagnosed-due-to-a-lack-of-awareness/">years to diagnose</a>. Consequently, individuals with undiagnosed endometriosis endure severe pain without understanding its cause, often coming to a point where daily activities become challenging. Too specific?</p><p>A more common example targets the broad area of cardiovascular health. <br>Recent research has revealed that women exhibit different <a href="https://www.nhlbi.nih.gov/health/heart-attack/women">heart attack</a> symptoms than their <a href="https://www.healthdirect.gov.au/heart-attack-symptoms-males-vs-females">male counterparts</a>, shockingly resulting in <a href="https://www.bhf.org.uk/what-we-do/news-from-the-bhf/news-archive/2016/august/women-are-50-per-cent-more-likely-than-men-to-be-given-incorrect-diagnosis-following-a-heart-attack#:~:text=Women%20are%2050%25%20more%20likely,diagnosis%20following%20a%20heart%20attack&amp;text=Women%20have%20a%2050%20per,new%20study%20we%20part%2Dfunded.">50% misdiagnosis following a heart attack</a>. These disparities place female individuals at an elevated risk of severe undetected health conditions.</p><p>The Femtech industry aims to address these gaps by developing products and services specifically designed for women&#39;s health. Since <a href="https://www.linkedin.com/in/idatin/">Ida Tin</a> (founder of Clue and &quot;mother of the term femtech&quot;) coined the term in 2016, this space has grown from a modest $100 million investment sector to a multi-billion-dollar global industry expected to reach <a href="https://www.statista.com/statistics/1483460/femtech-market-size-worldwide/">$120 billion by 2029</a>.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*1kOQ4PgxhkXc4vqJZyuYuQ.png" /><figcaption>Source: <a href="https://www.statista.com/statistics/1483460/femtech-market-size-worldwide/">Statista</a></figcaption></figure><p>Femtech is not limited to reproductive health. It spans digital tools for menstrual tracking, menopause support, fitness, and mental health, as well as devices for endometriosis and polycystic ovary syndrome (PCOS). Despite this growth, Femtech still faces valid feminist critiques. <a href="https://link.springer.com/book/10.1007/978-981-99-5605-0">Much of the market and product design centers around a narrow, often Western, white, heterosexual, and cisgender perspective. This &quot;one-size-fits-all&quot; model fails to address the diversity of experiences within women&#39;s health, particularly for women of color, LGBTQIA+ individuals, or those in underserved, low-income communities.</a></p><p>Femtech has enormous potential to democratize women&#39;s health and reduce the &quot;<a href="https://femtechnology.org/wp-content/uploads/2019/07/Copy-of-Gender-Data-Health-Gap-PFG.pdf">gender data gap</a>&quot; that leaves so many health issues under-researched. But it also risks commodifying women&#39;s bodies in ways that don&#39;t always serve their best interests. Critics rightly point out concerns about <a href="https://www.femtechworld.co.uk/news/researchers-expose-security-privacy-and-safety-issues-in-femtech/">privacy and data management within Femtech </a>— after all, menstrual and reproductive data can be sensitive, and in specific contexts, its misuse could be harmful. This critique is particularly relevant in Germany, where data protection laws are among the strictest globally. Many Femtech products collect <a href="https://www.researchgate.net/publication/361925277_Bodies_Like_Yours_Enquiring_Data_Privacy_in_FemTech">extensive personal data</a>, often with minimal transparency about how this information is used or shared. It&#39;s a delicate balance: Femtech is creating solutions to empower women, but without careful oversight, it could also reinforce existing inequalities and invade privacy.</p><p>According to <a href="https://www.sie.ventures/femtech-report-download">Sie Ventures Report</a> on Femtech in Europe, Germany is the third most significant player, set to reach a potential of $35 billion by 2032. The Femtech landscape is increasing, with startups tackling everything from hormonal health and fertility to menopause. Germany has the potential to set a new standard for Femtech in Europe that prioritizes inclusivity, data privacy, and a feminist approach to health — an excellent example of that tendency is <a href="https://www.everyhealth.me/de">Every Health*</a>.</p><p>That shows perfectly that the femtech market is more than a business opportunity — it&#39;s part of a movement to reconstruct healthcare for FLINTA (Female, Lesbian, Intersex, Non-binary, Trans, and Agender) individuals. By the way, did you know that <a href="https://www.vestbee.com/blog/articles/femtech-market-overview">7<strong>0% of femtech</strong></a><strong> startups in Germany are founded or co-founded by women?</strong>🧑‍🔬👩‍⚕️ And that&#39;s more than a number; it shows that women are stepping in for themselves because no one did it before — because it didn&#39;t matter. Additionally, by embracing a critical and inclusive lens, Germany&#39;s femtech industry can address the potential pitfalls of a rapidly growing sector and the neglect of gender-equitable health. However, even if most founders within the femtech sector are female, we still have a <a href="https://www.forbes.com/sites/dariashunina/2024/02/09/femtech-startups-uphill-battle-for---funding/">huge funding gap between male and female founders for femtech startups</a>. Sylvia Kang, the CEO at Mira said</p><blockquote><em>“70% of startups in the FemTech sector are female-founded. Despite this fact, male-founded femtech companies tend to raise much more capital. On average, female-founded FemTech startups have raised $4.6 million, compared to $9.2 million by male-owned companies.”</em></blockquote><h3>Key Segments and Leading Startups in 🇩🇪 Femtech 💡</h3><p>As you might have noticed by now, there is a huge potential in the German Femtech sector, and innovations are buzzing. From blood tests helping with hormonal balance diagnosis to AI detecting breast cancer or porn specially designed for female pleasure — the startups are tackling health and wellbeing needs with a <strong>BOLD</strong> vision. Below, you can see the market map of the Femtech landscape in Germany in 2024 — each area addresses a unique aspect of FLINTA health. Let&#39;s dive into the segments making waves and meet the outstanding startups behind them. 🌊✨</p><p><em>Disclaimer: This article focuses on the current German femtech market. I, therefore, only used the relevant segmentations from the femtech market definition. If you want to transfer the analysis to the whole European market, I suggest a more narrow definition of each segment. Example: One field in my segmentation is for chronic disease and prevention. If you look at the European market, it is separated into chronic disease, cancer, prevention, and more.</em></p><p>The segments I choose for my market map are sexual wellbeing, nongender pathologies, menopause, menstruation, hormonal health, maternity/postpartum, fertility, chronic diseases, and prevention, wellness, and lifestyle.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*0Bl7KCC8qvl2fN8FyjUEVg.png" /><figcaption>If your startup is part of the German femtech sector but isn’t included here, please reach out, and I’ll be happy to add you! 😊</figcaption></figure><p><strong>Sexual Wellbeing</strong>🌹: Sexual Wellbeing has the potential to impact FLINTA&#39;s life worldwide. This segment has been <a href="https://www.modernretail.co/operations/it-makes-business-sense-why-access-vc-is-funding-in-sexual-wellness-companies/">neglected for years.</a> One could argue that sexual wellness isn&#39;t crucial for the general society. It&#39;s more a matter of private pleasure — but let&#39;s be honest, that&#39;s not true. Sexual wellness encompasses much more; it involves educating individuals about the health risks associated with sexual activity, breaking taboos, challenging social norms, and embracing the idea of pleasure.</p><p>It&#39;s not solely about sexual freedom for women through porn or the use of vibrators; it also means reducing the risk of sexually transmitted infections (STIs). With the option to efficiently conduct STI tests at home, individuals can do so privately and without shame. But what does this mean for investors? I understand that some of you may feel uneasy discussing sexual wellbeing as it may not align with your typical investment thesis or LP&#39;s.🫨 Nevertheless, the market potential speaks for itself. According to <a href="https://sifted.eu/articles/sextech-fundraising">Sifted</a>, the SexTech market will reach a potential of <strong>$120 billion by 2030 </strong>worldwide. W<a href="https://sifted.eu/articles/sextech-fundraising">e have to appreciate the market potential!</a> What does that mean? It means be bold and take the risk because you will succeed — the financial returns will come. Let&#39;s have a look at some buzzing startups 🔥</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*ZVfRlBddj5iIT8b7qSPARQ.png" /></figure><ul><li><a href="https://www.femtasy.com/de"><strong>Femtasy</strong></a><strong>: </strong>The<strong> </strong>Berlin-based startup is offering erotic audio specifically designed for women. Their goal is to liberate pleasure and empower women to explore their fantasies. Femtasty was founded in 2018 by <a href="https://www.linkedin.com/in/ninajulie/">Nina Julie Lepique</a> and was initially ridiculed for its idea. <a href="https://www.gruender.de/gruendung/femtasy-gruenderin/">However, this didn&#39;t stop femtasy from achieving over one million monthly views and a single-digit million turnover yearly.</a> The start-up has also raised 3.17 million euros from several angel investors.</li><li><a href="https://nevernot.de/"><strong>Nevernot</strong></a>: A <a href="https://nevernot.de/en/pages/der-nevernot-tampon-der-neue-soft-tampon?srsltid=AfmBOooQpU3lSuUWJFtKpiKLMfSAtafemKCN5MR9ARJHkKbgFaslLwiL">soft tampon</a> brand that wants to bring the solution to a broader audience because, at the moment, most sex workers rely on them because they can stay inside while having sex. Of course, this is not the only benefit especially people with uterus problems who have extreme pelvic pain should consider this alternative, as they are exceptionally adaptable. They are also dermatologically and gynaecologically tested, vegan and cruelty-free. Nevernot was founded by Katharina Trebitsch and Anna Kössl in 2022, and <a href="https://www.startbase.de/news/nevernot-schliesst-erste-finanzierungsrunde-ab/">their investment was mainly raised through prominent angel investors</a>.</li></ul><p><strong>Hormonal Health</strong>🩷: <strong>Hormonal Health</strong> plays a crucial role in women&#39;s wellness, encompassing natural cycle tracking, balanced nutrition, mental well-being, and overall personal health. <a href="https://www.hopkinsmedicine.org/health/wellness-and-prevention/can-menopause-cause-depression#:~:text=Falling%20estrogen%20and%20progesterone%20levels,major%20depression%20in%20the%20past.">Hormonal imbalances are strongly linked to an increased risk of depression in females</a>, underscoring the need for a comprehensive approach that looks beyond just progesterone and estrogen levels. The market&#39;s expansion reflects the growing awareness around hormonal health.<br>According to <a href="https://finance.yahoo.com/news/women-hormonal-supplements-market-size-133100547.html">SNS Insider Research</a>, the <strong>women&#39;s hormonal supplements market</strong> was valued at <strong>$ 4.50 billion in 2023</strong> and is expected to nearly double to <strong>$ 8.50 billion by 2032</strong>, with a <strong>CAGR of 7.6%</strong> over the 2024–2032 forecast period. This growth underscores a rising demand for comprehensive solutions that address the full spectrum of hormonal health, emphasizing physical and mental well-being. Let us now take a closer look at two examples.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*jdOw4XETkiqjC1DYhHOTRw.png" /></figure><ul><li><a href="https://helloclue.com/de/ueber-clue"><strong>Clue</strong></a><strong>: </strong>Clue is a Berlin-based pioneer femtech startup founded by Ida Tin in 2008 with the mission to live in sync with your cycle. They have 11 million active Users in 190 countries and just launched their first <a href="https://helloclue.com/articles/about-clue/clue-launches-first-ever-community-investment-round">community investment</a> round. Before that, <a href="https://sifted.eu/articles/clue-digital-contraceptive-period-tracker">Clue</a> <a href="https://www.futurepositivecapital.com/companies/clue">raised €7 million from existing investors led by Balderton Capital and Union Square Ventures</a>. Clue offers holistic menstrual cycle tracking, which means you can add your current moods or find specific articles based on your issues. They also provide tracking options for problems and conditions. Over 11 million users are actively using Clue in 190 countries. Let&#39;s keep in mind that alone in Germany, <a href="https://de.statista.com/themen/10351/periodenprodukte/#:~:text=Viele%20Menstruierende%20verwenden%20diese%20Art,im%20Jahr%202021%20sogar%20t%C3%A4glich.">12.6 million people</a> are menstruating, and <a href="https://de.statista.com/outlook/hmo/digital-health/digitale-behandlung-pflege/digital-care-management/verhuetungs-und-fruchtbarkeits-apps/deutschland">2 million</a> of them are using a paid cycle tracking app. The user rate is projected to grow to 2.6 million by 2029. As you can see, the potential is enormous.</li><li><a href="https://www.theblood.io/"><strong>theblood</strong></a>: As the name might suggest, they focus on menstrual blood analysis and biomarkers and the development of a noninvasive blood at-home test that helps menstruators monitor their health. This means that vitamin D, testosterone, or progesterone values are determined at home. The aim is for customers to reduce menstrual cramps or adapt their eating habits, for example. Science supports this approach because, according to <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3494145/">a 2012 study</a>, almost 400 proteins can be detected in menstrual blood that are otherwise not found. The PoC was achieved in 2023 by successfully testing their blood test on 50 active users. The next step is enrolling in a clinical trial with hundreds of patients to validate the procedure. Theblood was founded by Isabelle Guenou and Miriam Santer in 2022 and raised <a href="https://www.businessinsider.de/gruenderszene/health/theblood-analyse-menstruation-blut-we/">€1M in pre-seed funding</a>. The round was led by RoX Health, with participation from Leanox VC and several angel investors.</li><li><strong>Chronic Diseases &amp; Prevention</strong>🎗️&amp; 🌼: Breast cancer serves as an example of a chronic disease and is the most common cancer affecting <a href="https://www.europadonna.org/breast-cancer/#:~:text=Breast%20cancer%20is%20the%20most%20common%20cancer%20in%20women%20in,before%20the%20age%20of%2074*.">women in Europe</a>. The European Cancer Information System reports that the mortality rate for women with breast cancer in Europe is projected to rise by 23% between 2022 and 2040. My goal in sharing this is not to incite panic or despair but to spread hope. Over recent years, there has been a significant shift in this sector globally, with breast cancer research and innovation now receiving substantial funding — $2.7 billion over the past four years. The breast cancer market is projected to grow by an additional <a href="https://www.precedenceresearch.com/breast-cancer-market"><strong>$74 billion by 2032</strong></a><strong>.<br></strong>However, breast cancer is only one part of the picture. Founders in the Femtech space also drive innovations across other chronic conditions and preventative care, including pelvic health, gynecological health, endometriosis, cervical cancer, sexual health, and more. These advancements range from next-generation devices and consumer products to comprehensive patient support solutions, reshaping the future of women&#39;s health. Let&#39;s have a look at some buzzing startups 🔥</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*1R3fKqQk752I_0O0qofMow.png" /></figure><ul><li><a href="https://www.vara.ai/about-us"><strong>Vara</strong></a>: Vara is an AI-powered breast cancer screening platform designed to optimize the entire screening process, from appointments to reporting. It improves cancer detection through features like a &quot;Safety Net,&quot; which triggers when the AI identifies a highly suspicious region that the radiologist has marked as unfavorable, prompting them to reconsider and potentially catch missed cancers. This is critical as <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6640096/#:~:text=In%20the%20under%2050%20group,%2C%2095%25%20sensitivity%20was%20recorded.">mammograms miss 56% of tumors</a>, and in Germany, where 3 million women are screened annually under a double-read system, <a href="https://www.vara.ai/decision-referral">69% of cancers are detected by only one radiologist. Additionally, 12% of cases require a consensus conference, and 4% are recalled for further imaging, often causing stress for patients. </a>Vara aims to reduce unnecessary recalls and improve accuracy while facilitating collaboration with tools for consensus and second opinions and providing actionable insights for clinicians, health systems, and researchers. Vara just raised <a href="https://www.vara.ai/press-releases/vara-raises-8-9m-expands-ai-breast-cancer-detection-india">$8.9 million in funding</a>, led by European family offices Smart Family Office and FJH, alongside IBB Ventures.</li><li><a href="https://diga.endometriose.app/#toggle-id-3"><strong>Endo Health</strong></a><strong>:</strong> A <a href="https://www.femtechworld.co.uk/qa/meet-germanys-first-health-app-dedicated-to-endometriosis/">Chemnitz-based Startup</a> founded in 2020 by Nadine Rohloff and received Seed funding of more than 1 million euros. Endometriosis affects alone in Germany <a href="https://www.mhh.de/presse-news/endometriose-eine-krankheit-mit-vielen-gesichtern#:~:text=Hermann%20Hertel%3A%20Endometriose%20ist%20eine,40.000%20Neuerkrankungen%20pro%20Jahr%20aus.">2 million women, with an indicated growth of 40000 new patients yearly.</a> Because, on average, it typically takes 7 years from the onset of the first symptoms to a diagnosis. Endo Health is helping to spread awareness regarding the disease and manage symptoms if diagnosed. From pain management tips to support networks, Endo Health reminds women they aren&#39;t alone in their journey. The German state also sees the existing need; they received pre-seed funding as part of the state funding program of Saxony and were part of <a href="https://startup-mitteldeutschland.de/startup-storys/sachsen/spinlab-start-klasse-13/">SpinLab — The HHL Accelerator</a>. Furthermore, seed funding was provided in 2022, but it is unclear from the available sources who are involved as investors.</li></ul><p><strong>Maternity &amp; Postpartum</strong> 🤰&amp; 👶 <strong>:</strong> The maturity level of maternal health startups is enormous compared to other segments. A vague theory might be related to the fact that women getting pregnant is as old as humanity itself. Compared to other femtech sectors, the stigma is much lower, and the social awareness is more prominent, but it doesn&#39;t lack innovation. There is a broad range of maternal and fetal screening, clinical, emotional, financial support, education, and more. And let&#39;s not forget it&#39;s not just about being pregnant and giving birth to a baby — it&#39;s also about caring for the mom/person postpartum. <a href="https://www.grandviewresearch.com/horizon/outlook/postpartum-products-market/europe#:~:text=The%20postpartum%20products%20market%20in,market%20from%202024%20to%202030.">Horizon</a> states that until 2030, the postpartum market in <strong>Europe alone will reach a potential revenue of $ 659.7 million</strong>. Existing products relevant to this market are, for example, breastfeeding pumps or cooling pads. Let&#39;s have a look at some buzzing startups 🔥</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*KQnsr2iKhpjK6Zh1GE5OfQ.png" /></figure><ul><li><a href="https://keleya.de/"><strong>Keleya</strong></a>: Keleya is a Berlin-based Startup founded by Victoria Engelhardt in 2017 and received <a href="https://how-to-business.handelsblatt.com/person/victoria-engelhardt/">€3M Series A</a> from prominent femtech Venture Capital Investors such as <a href="https://www.calmstorm.vc/portfolio/keleya">Calm/Storm Ventures</a>, Crista-Galli Ventures, and SeedLink SL to expand and continue growing both its signature app for parents-to-be and its sister site Ammely, a midwife matching platform. A special feature at this point is that almost all German health insurance companies cover the costs of using the app. Socially, this creates an inclusive factor and offers all expectant mothers and mothers who have allowed birth to benefit from support regardless of their income. The importance of such pre-and postnatal care is undeniable because, in Germany alone, <a href="https://www.deine-gesundheitswelt.de/schwangerschaft-geburt/schwangerschaftsdepression">12 out of 100 women</a> are affected by pregnancy depression and <a href="https://www.deutsche-depressionshilfe.de/depression-infos-und-hilfe/depression-in-verschiedenen-facetten/in-der-schwangerschaft-und-nach-der-geburt">10–15% by postpartum depression</a> after giving birth. Keleya actively counteracts this, e.g., by offering autogenic training.</li><li><a href="https://momunity.com/"><strong>Momunity</strong></a>: Momunity is a <a href="https://www.bouncewatch.com/explore/startup/momunity">social app</a> launched in 2017 that provides a platform for mothers and pregnant women to connect, communicate, exchange recommendations, and form new friendships. It is free of charge, allowing women from all societal backgrounds to participate in a safe community. Momunity, founded by Lena-Charlotte Schiweck, received its last investment in a seed round in 2018 through PANDO Ventures.</li></ul><p><strong>Fertility</strong> 🥚: Fertility in Femtech encompasses various reproductive health innovations, from advanced IVF treatments to daily fertility tracking apps3 and clinic data management tools. This segment is designed to support individuals on their fertility journeys, making personalized, accessible care a reality.<br>With its rapid growth, fertility technology has emerged as one of Femtech&#39;s most dynamic areas, drawing substantial interest from investors. According to Dealroom, the fertility sector has secured $1.1 billion in venture capital over the past five years and is projected to reach $1.6 billion soon. These numbers underscore the rising demand for innovative fertility solutions and the immense potential within this Femtech segment. Let&#39;s look at two pioneering German startups 🔍.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*Gk-HcdPSSChKsSxk-Xx2ow.png" /></figure><ul><li><a href="https://www.inne.io/en/home"><strong>inne</strong></a>: Since launching the minilab and receiving medical device regulation in 2019, inne has helped thousands of women across Germany, Switzerland, Austria, and the UK to track their progesterone levels with the app processing over 100,000 hormonal data points. Some people are wondering why this is relevant—women&#39;s hormonal cycle influences, among other things, performance and mental and physical health. Therefore, a holistic approach to tracking and improving hormone health is relevant to minimize the long-term negative consequences of neglected hormone health. Eirini Rapti founded the startup, and they <a href="https://www.inne.io/en/blog/article/inne-raises-10-million-to-expand-its-hormone-tracking-tech">raised $10 million</a> in funding led by DSM Venturing.</li><li><a href="https://www.ovomcare.com/"><strong>Ovom</strong></a><strong>: </strong><a href="https://www.eu-startups.com/2024/04/berlin-based-ovom-care-secures-e4-8-million-to-advance-ai-driven-fertility-care/#:~:text=FundingGermany%2DStartups-,Berlin%2Dbased%20Ovom%20Care%20secures%20%E2%82%AC4.8%20Million,advance%20AI%2Ddriven%20fertility%20care&amp;text=Ovom%20Care%2C%20a%20pioneering%20digital,round%20of%20%E2%82%AC4.8%20million.">Ovom</a> brings a science-backed approach to fertility tracking, offering couples insights into family planning. Integrating AI-enabled and data-driven medical care into the modern fertility care infrastructure marks a significant leap forward, especially in IVF treatment and egg freezing. Alone in Germany, about every <a href="https://www.gynaekologische-psychosomatik.de/themen/unerfuellter-kinderwunsch/">6th to 7th partnership</a> remains unintentionally childless, which puts a lot of pressure on the relationship and mental health. Ovom&#39;s mission is to reduce the stress and enhance the quality of fertility treatment. <a href="https://www.businessinsider.de/gruenderszene/business/kinderwunsch-mit-ki-mit-9-slides-ueberzeugten-diese-gruenderinnen-mehrere-investoren/">They</a> successfully closed their Seed funding with €4.8 million, led by Alpha Intelligence Capital and supported by Ananda Impact Ventures and Merantix. It was founded in 2023 by Felicia von Reden, Dr.Lynae Brayboy, and Dr. Cristina Hickman.</li></ul><p><strong>Menopause</strong> 🌺: Menopause is nearly as untapped as the sexual wellness segment. Maybe because in our Western society, both aren&#39;t attractive — female pleasure or women aging &quot;Bye&quot;. Well, that&#39;s a little pity because the founder and managing director of Better Ventures, Tina Dreimann said, &quot;<strong>The menopause market is estimated at $600 billion</strong>, <strong>but only 5 percent of femtech startups focus on menopause.&quot;</strong> Menopause typically happens between 45 and 55 years old women, it is deemed if 12 months have passed without menstruation. According to the German Menopause Society, <a href="https://www.frauenaerzte-im-netz.de/aktuelles/meldung/deutsche-menopause-gesellschaft-empfiehlt-individuelle-aufklaerung-und-beratung-rund-um-hormonersatzt/">9 million women</a> are currently going through menopause. During the transition phase, women are affected by symptoms such as mood swings, anxiety, hot flashes, difficulty sleeping, vaginal dryness, reduced sex drive, memory or concentration problems, and much more. From my point of view, the goal would be to support each individual going through the different stages: pre-/during and post. The only problem is that the current solutions don&#39;t fit that. A lot of women feel unprepared and left alone.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*Mx5u1UjH3hmIaik4d5AUbg.png" /></figure><ul><li><a href="https://drvivienkarl.com/"><strong>Dr.Vivien Karl</strong>:</a> They offer an intimate cream that helps against vaginal dryness because they are convinced that the market is lacking high-quality products for the female population. By developing a product specifically for women going through menopause, Dr. Vivien Karl is actively contributing to destigmatization and, in the long term, to normalization in society. They actively support the idea that women can age as gracefully as men do. The startup was founded in 2021 by Vivien Karl and Julia Huhnholz. So far, they have raised a <a href="https://www.startbase.com/news/femtech-dr-vivien-karl-erhaelt-geld/">six-figure</a> amount in its pre-seed funding through better ventures and more.</li><li><a href="https://www.frieda.health/"><strong>Frieda Health</strong></a>: The <a href="https://femtechinsider.com/frieda-health-pre-seede/">platform </a>integrates medical and psychological expertise with digital technology. Its goal is to provide holistic support because, in Germany alone, around<a href="https://www.rbb-online.de/rbbpraxis/rbb_praxis_service/gehirn-nerven-psyche/psychologie/wenn-psychische-symptome-den-alltag-beschweren-hilfe-menopause-wechseljahre.html#:~:text=Prof.-,Dr.,%2C%20Unruhe%2C%20Panikattacken%20oder%20Konzentrationsst%C3%B6rungen."> 20% of women suffer from depression, sleep disorders, massive exhaustion, restlessness, panic attacks, or concentration disorders during menopause</a>. The Startup was founded by Valentina Ullrich, Dr. Kai Schulze-Wundling, and Thanh Schrader-Nguyen in 2020 and secured <a href="https://startupvalley.news/de/frieda-health/">€2.5 million in pre-seed</a> funding from the Maximon Longevity Co-Investment Fund.</li></ul><p><strong>Non-Gender Pathologies</strong> 🌍: This segment focuses specifically on solutions, products, and services designed not only for individuals identifying as female but also for non-binary, trans, intersex, and agender individuals. In Germany, it&#39;s estimated that approximately 4<strong>% of the population</strong> identifies as non-binary, trans, or gender-diverse — representing hundreds of thousands of potential users whose health needs are often overlooked. With this inclusivity in mind, the Femtech sector addresses a broader spectrum of health issues and opens new avenues for growth. Let&#39;s explore some exciting startups leading the way in inclusive healthcare! 🔥</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*qdjK7vnxbQXaWEy2JHH-Cw.png" /></figure><ul><li><a href="https://www.everyhealth.me/"><strong>Every Health*</strong></a><strong>:</strong> Every Health* is a pre-seed health platform built by and for the LGBTQIA+ community. It is designed to create a safer, more inclusive space where everyone is seen, heard, and respected. With a team deeply knowledgeable about LGBTQIA+ health issues, Every Health* offers specialized care tailored to the unique needs and experiences within the community. This isn&#39;t just healthcare—it&#39;s empowerment. The startup was founded in 2023 by Dimitri Bilyarchyk and has received money from prominent business angles.</li></ul><p><strong>Menstruation🩸: Menstrual Health</strong> within Femtech is transforming, moving beyond the one-size-fits-all approach of traditional tampons and pads. Today, personalization is the key driver, with options ranging from menstrual cups and sponges to CBD-infused tampons and products that monitor microbiome health. This shift reflects the sector&#39;s broader goal of addressing many women&#39;s health needs, not just managing menstruation.<br>The potential in this space is reflected in the numbers. <a href="https://www.globenewswire.com/news-release/2023/06/29/2697026/0/en/The-Europe-feminine-hygiene-products-market-was-valued-at-US-6-47-billion-in-2021-and-is-expected-to-reach-US-8-14-billion-by-2028-it-is-estimated-to-register-a-CAGR-of-3-4-from-20.html">The European feminine hygiene</a> products market was valued at <strong>USD 6.7 billion in 2022</strong> and is expected to reach <strong>USD 8.1 billion by 2028</strong>, with a CAGR of 3.4%. Menstrual health innovation goes hand in hand with hormonal health, offering products that prioritize a holistic approach to wellness.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*wiqbj8MU65FBA6_Pp_maTQ.png" /></figure><ul><li><a href="https://www.vyldness.de/"><strong>Vyld</strong></a><strong>: </strong>The startup offers a sustainable and<strong> </strong>health-safe alternative to existing tampons because they are made of seaweed, which is compostable. The health benefit they offer is immense because a recent study of the <a href="https://www.sciencedirect.com/science/article/pii/S0160412024004355?via%3Dihub">UC Barkely</a> has just shown that metal was detected in all Tampos they studied. The lead concentration was higher in non-organic tampons, whereas arsenic was higher in organic tampons. This is associated with a potentially higher risk of dementia, infertility, diabetes, and cancer. They are priced at around 14,99 for 16 tampons. The startup is founded by Ines Schiller in 2021 and has already secured <a href="https://femtechinsider.com/vyld-funding-round/">seven-figure funding</a> from the EU and the German state. Furthermore, they used an FPPA and a non-equity crowdfunding campaign.</li><li><a href="https://buy.thefemalecompany.com/"><strong>The Female Company</strong></a><strong>: </strong>Is<strong> </strong>another excellent example of menstruation products. The Female Company offers a wide range of products like period underwear, tampons, slips, menstruation cups, chlamydia tests, and more. Over the last years, they have also diversified their product portfolio by offering bras, underwear specifically reinforced against leakage and mompanty for childbed. The company was founded in 2018 by Ann-Sophie Claus and Sinja Stadelmaier shortly after a model lost one leg because of a toxic shock syndrome triggered by a tampon. That was their inspiration, they wanted to reshape the market and offer &quot;cruelty free&quot; tampons. The Female Company is raising <a href="https://buy.thefemalecompany.com/pages/crowdinvest?srsltid=AfmBOoop50nOhsmt6YkAZevz0ATkbLVd0s5eEgbwlutp6C0PgR2nQvZ0">€1.5 million through a crowdfunding campaign</a> after receiving angel investments to change the femtech industry even further.</li></ul><p><strong>Wellness and Lifestyle 💃:</strong> It&#39;s about the empowerment to choose a healthy lifestyle with the supplements you need or the desired consumer products. That one isn&#39;t a niche market segment in the femtech sector because the barriers are pretty low compared to other segments. Nevertheless, that doesn&#39;t mean they are less valuable in contributing to our society. Focus areas are hormonal supplements, intestinal health, and empowering period-friendly workplaces through workshops.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*Q_6tPPB0aNt1anSK7gmRmA.png" /></figure><ul><li><a href="https://femna.de/"><strong>Femna Health</strong></a>: Femna Health is a women&#39;s health company focused on natural solutions for hormonal balance, menstrual health, and menopause support. Through evidence-based herbal products and expert consultations, Femna provides women with accessible, personalized health resources. Currently, in its seed funding stage, Femna aims to empower women with proactive, holistic health options tailored to every life stage. The Startup was founded by Maxie Matthiessen in 2016. They received <a href="https://siliconcanals.com/de/femna-health-bags-seven-figure-funding/">seven-figure funding</a> through IBB Capital, among others.</li><li><a href="https://her.one/pages/black-weeks?trc_gcmp_id=1742846598&amp;trc_gag_id=67716883429&amp;trc_gad_id=524025717599&amp;kb=ga_sb_1742846598_67716883429&amp;utm_source=google&amp;utm_medium=cpc&amp;utm_campaign=BrandDACHR55&amp;utm_content=all&amp;gad_source=1&amp;gclid=Cj0KCQiA57G5BhDUARIsACgCYnx9idSVHyNMlMnKf0zXnvL-Tbmsszq9wuOgIJ_R424ZsHJSZn9b0hsaAnp9EALw_wcB"><strong>her1</strong></a>: Founded by Chanyu Xu and Rita Ugwu in 2019, the Startup provides natural, plant-based products to boost gut health and aid women&#39;s health and beauty from within. Five Seasons Ventures led the last funding round, with participation from previous seed investors Rheingau Founders and IBB Ventures. HerOne received a Series A funding of <a href="https://www.finsmes.com/2021/07/her1-raises-e5-5m-in-series-a-funding.html#google_vignette">€5.5 million.</a></li></ul><h3><strong>Investment Landscape: Untapped Potential Awaits 🚀</strong></h3><p><strong>Germany&#39;s</strong> Femtech startup scene is on🔥 — innovative, promising, and ready to reshape women&#39;s health. But here&#39;s the catch: while the startups are brimming with potential, the venture capital side of things is still catching up. Unlike in the UK, US, or other European countries where Femtech VC investment is solid and steady, Germany is missing out on major national backers who could elevate this sector to the next level. Right now, it&#39;s a story of <em>untapped potential</em>. And yes, before anyone comes at me, some VCs have taken isolated investments but not in a broader range. Therefore, I created an overview of the VCs invested in the Startups mentioned above.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*2_tefkgYFvXxpiJDBypIUw.png" /><figcaption>If you aren’t included but are currently investing in the German Femtech Market — Please write me, and I’ll add you😊</figcaption></figure><p><strong>So, what&#39;s holding back the cash flow?</strong></p><p>Globally, Femtech-focused VC funds like Calm/Storm Ventures, SieVentures, Octopus Ventures, and General Catalyst support women&#39;s health tech. The card below provides an overview of the geographical landscape where the most influential VCs in the femtech scene are based.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*6EwRzoZ_PynBnSn20P4guA.png" /><figcaption>If you aren’t included but are currently investing in the Femtech Market — Please write me, and I’ll add you😊</figcaption></figure><p><a href="https://pitchbook.com/news/articles/most-active-femtech-vc-investors">Pitchbook</a> and <a href="https://www.vestbee.com/blog/articles/most-active-vc-funds-investing-in-european-femtech-startups">Vestbee</a> highlighted that none of the top global Femtech investors are based in Germany, leaving local startups with fewer VC funding options and often forcing them to look abroad for backing — a missed opportunity for German investors looking to ride the Femtech wave. But not for the startups; they get &quot;creative&quot; with other funding options such as crowdfunding, family offices, or angel investors — that means Germany is not entirely missing out — one could only argue there is growth potential for VCs.</p><p><strong>Why Invest in German Femtech? 🎯</strong></p><p>Germany&#39;s Femtech startups aren&#39;t just good investments; they create real impact and societal change. With the market projected to grow across Europe, German Femtech is a prime opportunity for VC firms ready to leap into this rapidly expanding field. With consumer demand high and a new generation of health-conscious users looking for solutions that fit their lives, there&#39;s no better time for German investors to step up and support these startups. The payoff isn&#39;t just financial — it&#39;s social, cultural, and groundbreaking for women&#39;s health. 🌍💪</p><p>As more investors recognize this potential, Germany&#39;s Femtech scene has every chance of transforming into a powerhouse of women&#39;s health innovation. And for those ready to join the journey? The rewards could be substantial in terms of returns and positive impact. 🌱</p><h3>Trends in German Femtech: 2024&#39;s Hottest Topics 🔥✨</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/480/0*JYQmGUrBumfe5x7V.gif" /><figcaption>three, two, one..</figcaption></figure><p>Femtech in Germany is heating up, with 2024 bringing forward innovative trends redefining women&#39;s health. Here are the top areas making waves in the German Femtech scene right now 🚀🌍.</p><p><strong>🌱 Advanced Maternal Care<br></strong>Maternal care has become a top priority, with apps and wearables supporting moms throughout their pregnancy and postpartum journey. From real-time health tracking to personalized guidance, advanced maternal care solutions are empowering women to feel supported every step of the way.</p><p><strong>🌸 Menopause Management<br></strong>Menopause is finally getting the attention it deserves! Digital tools and wellness products are emerging to help women manage symptoms like hot flashes, mood swings, and sleep disruptions. This trend is about breaking the silence around menopause and empowering women to embrace this life stage confidently and efficiently. 💪</p><p><strong>🧬 Precision Oncology<br></strong>Early cancer detection is critical, and Femtech is stepping up with tools for breast and ovarian cancer screening. Precision oncology solutions are using AI and data analytics to catch these cancers sooner, providing women with the opportunity for timely and potentially life-saving treatment. 🎗️</p><h3>The Future of Femtech in Germany: Paving the Way for Innovation 🌟🇩🇪</h3><p><strong>Germany&#39;s</strong> Femtech market has shown incredible potential, and it&#39;s only just beginning. With a strong foundation of innovative startups, growing consumer demand, and increasing awareness around women&#39;s health issues, the future looks bright for Femtech in Germany! 🚀</p><p>But let&#39;s be real: there&#39;s still work to be done. From increasing inclusivity to expanding access to venture capital, Germany&#39;s Femtech scene faces a few key challenges on its path to becoming a global leader in women&#39;s health technology.</p><p><strong>🌍 Expanding Inclusivity and Accessibility<br></strong>One of the most significant growth opportunities is making Femtech more inclusive. Currently, many solutions are designed with a Western perspective, which can overlook the needs of women from diverse backgrounds. Future Femtech products should embrace a broader range of women&#39;s experiences, ensuring that health solutions are accessible and relevant for everyone, regardless of culture, ethnicity, or socioeconomic status. 🌈</p><p><strong>💸 Attracting More Investment<br></strong>Germany&#39;s Femtech startups are brimming with potential, but the sector needs more robust investment to scale effectively. With most of the major Femtech investors based outside Germany, there&#39;s a huge opportunity for local VCs to step in and support this growing field. Increased funding will help these startups scale, innovate, and compete globally, making Germany a true Femtech powerhouse. 💪</p><p><strong>💡 Embracing Technological Advancements<br></strong>AI, data analytics, and wearable technology are just a few tools driving Femtech&#39;s evolution. By embracing these technologies, German Femtech can lead the development of personalized, precise, and proactive health solutions. Imagine AI-driven apps that adapt to each user&#39;s unique health needs or wearables that provide real-time insights into hormonal health — these innovations are the future! 🤖✨</p><p><strong>🌸 Breaking Taboos and Raising Awareness<br></strong>From menstrual health to menopause, many women&#39;s health topics are still considered taboo. The Femtech sector in Germany has the power to change this narrative by creating open, supportive spaces for discussion and education. As more women learn about and engage with Femtech, these conversations normalize, paving the way for a more informed and empowered population. 🗣️❤️</p><h3>Conclusion: The not so &quot;Pink&quot; Femtech Revolution in 🇩🇪</h3><p>The Femtech movement is about much more than innovative technology; it&#39;s a decisive shift toward gender equity in healthcare, led by a mission to close the gender health gap. For too long, the health needs of FLINTA individuals have been sidelined, with women&#39;s symptoms often dismissed and conditions like endometriosis going undiagnosed for years. As Caroline Criado Perez aptly describes in <em>Invisible Women</em>,</p><blockquote>“The data gap is not a gap, it’s a chasm.”</blockquote><p>Femtech aims to bridge this divide with empathy and inclusivity, designing solutions that address the diverse and unique health experiences of those traditionally underserved by mainstream medicine. 🌍💖</p><p>But the Femtech mission in Germany goes beyond closing the data gap; it&#39;s about transforming healthcare. This sector doesn&#39;t just provide innovative solutions — it challenges the traditional, male-centered healthcare model by ensuring that race, sexuality, ability, and individual experiences shape the future of health. Femtech promises to empower individuals to take charge of their health by equipping them with tools that respect and reflect their identities. 🌈✨</p><p>Germany&#39;s Femtech sector is on the brink of extraordinary change. With pioneering startups innovating in maternal care, menopause, AI health assistants, and more, the potential for meaningful change is undeniable. Yet, for this movement to achieve its full impact, there is still work to be done: attracting more local investment, fostering broader inclusivity, and embracing cutting-edge technology. By meeting these needs, Germany can set new global standards in healthcare, making it accessible, personalized, and empowering.</p><p>Here&#39;s to a future where healthcare truly serves everyone — a future led by a Femtech revolution that is smart, supportive, and truly transformative. Germany is ready to make history in inclusive healthcare, and the journey is just beginning. 🌟👩‍⚕️💡</p><p><strong>A Note on Inclusivity in Femtech</strong> 🌍✨</p><p>While the term &quot;Femtech&quot; may sound gender-specific, it&#39;s important to recognize that the Femtech sector is inclusive of all FLINTA individuals — Female, Lesbian, Intersex, Non-binary, Trans, and Agender persons — who experience a range of unique health needs. This industry isn&#39;t solely about &quot;female&quot; health; it&#39;s about creating accessible, personalized healthcare solutions for anyone with reproductive health needs or those impacted by conditions that may be traditionally associated with women&#39;s health. As we explore the advancements in Femtech, let&#39;s remember that these innovations aim to serve and empower all individuals, regardless of gender identity, who face similar health challenges. 💪</p><p>Thank you for taking the time to read my Deep Dive into the German Femtech Market! If anything needs to be added or you&#39;d like to contact me, you can contact me, please do so on <a href="https://www.linkedin.com/in/anna-elena-freyhardt-ba2a671b4/">LinkedIn</a>. I am always open to a conversation!</p><p>Make sure to follow Included VC on <a href="https://x.com/included_vc">X</a> &amp; <a href="https://www.linkedin.com/company/includedvc/posts/?feedView=all">LinkedIn</a>.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=a9126e344d48" width="1" height="1" alt=""><hr><p><a href="https://medium.com/included-vc/beyond-pink-the-femtech-revolution-in-germany-a9126e344d48">Beyond Pink —  The Femtech Revolution in Germany</a> was originally published in <a href="https://medium.com/included-vc">Included VC</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
    </channel>
</rss>